Cytek Biosciences, Inc.
CTKBNASDAQHealthcare● Active
$4.04
$-0.05(-1.22%)
Market Cap$521736051
P/E Ratio—
52W High$6.18
52W Low$2.9
Cytek Biosciences, Inc. (CTKB) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CTKB · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.26B | $0.28B | $0.26B | $0.34B | $0.36B |
| Net Receivables | $0.07B | $0.06B | $0.06B | $0.05B | $0.03B |
| Inventory | $0.05B | $0.04B | $0.06B | $0.05B | $0.03B |
| Total Current Assets | $0.39B | $0.40B | $0.39B | $0.45B | $0.43B |
| PP&E Net | $0.03B | $0.03B | $0.03B | $0.03B | $0.01B |
| Goodwill | $0.02B | $0.02B | $0.02B | $0.01B | $0.01B |
| Intangible Assets | $0.02B | $0.02B | $0.02B | $0.00B | $0.00B |
| Total Assets | $0.46B | $0.50B | $0.49B | $0.52B | $0.46B |
| Liabilities | |||||
| Short-Term Debt | $0.01B | $0.00B | $0.00B | $0.00B | $0.00B |
| Accounts Payable | $0.01B | $0.01B | $0.00B | $0.00B | $0.00B |
| Total Current Liabilities | $0.08B | $0.07B | $0.06B | $0.05B | $0.03B |
| Long-Term Debt | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Liabilities | $0.12B | $0.10B | $0.10B | $0.09B | $0.06B |
| Stockholders Equity | |||||
| Retained Earnings | ($0.10B) | ($0.04B) | ($0.03B) | ($0.02B) | ($0.02B) |
| Total Stockholders Equity | $0.34B | $0.40B | $0.39B | $0.43B | $0.41B |
| Total Liab & Equity(computed) | $0.46B | $0.50B | $0.49B | $0.52B | $0.46B |
| Debt Summary | |||||
| Total Debt | $0.02B | $0.02B | $0.01B | $0.02B | $0.00B |
| Net Debt | ($0.07B) | ($0.08B) | ($0.15B) | ($0.28B) | ($0.36B) |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Cytek Biosciences, Inc. data
About Cytek Biosciences, Inc. (CTKB) Balance Sheet
Cytek Biosciences, Inc. (CTKB) balance sheet shows total assets of $0.46B with cash of $0.26B. Total liabilities are $0.12B, total debt $0.02B, and stockholders equity $0.34B.
Frequently asked questions
CTKB · 4 questionsCytek Biosciences, Inc. has total debt of $0.02B with net debt of ($0.07B).
CTKB total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10